BRAMANT Trademark

Trademark Overview


On Wednesday, June 15, 2005, a trademark application was filed for BRAMANT with the United States Patent and Trademark Office. The USPTO has given the BRAMANT trademark a serial number of 78651181. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 10, 2010. This trademark is owned by Pfizer Inc.. The BRAMANT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations and preparations for the treatment of gynecological disorders; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence
bramant

General Information


Serial Number78651181
Word MarkBRAMANT
Filing DateWednesday, June 15, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 10, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 16, 2007

Trademark Statements


Goods and Servicespharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol reducers, smoking cessation preparations, tissue and skin repair preparations and preparations for the treatment of gynecological disorders; pharmaceutical preparations, namely, pharmaceutical preparation for the treatment of anxiety, depression, pain, gastrointestinal disorders, neuropsychiatric disorders including both psychotic and non-psychotic conditions, neurodegenerative disorders; and substance abuse disorders, including both abuse and dependence

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 20, 2005
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, May 10, 2010ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, May 10, 2010ABANDONMENT - NO USE STATEMENT FILED
Tuesday, September 29, 2009EXTENSION 5 GRANTED
Tuesday, September 29, 2009EXTENSION 5 FILED
Tuesday, September 29, 2009TEAS EXTENSION RECEIVED
Wednesday, April 1, 2009EXTENSION 4 GRANTED
Wednesday, April 1, 2009EXTENSION 4 FILED
Wednesday, April 1, 2009TEAS EXTENSION RECEIVED
Monday, September 29, 2008EXTENSION 3 GRANTED
Monday, September 29, 2008EXTENSION 3 FILED
Monday, September 29, 2008TEAS EXTENSION RECEIVED
Monday, March 10, 2008EXTENSION 2 GRANTED
Monday, March 10, 2008EXTENSION 2 FILED
Monday, March 10, 2008TEAS EXTENSION RECEIVED
Wednesday, October 3, 2007EXTENSION 1 GRANTED
Monday, September 24, 2007EXTENSION 1 FILED
Monday, September 24, 2007TEAS EXTENSION RECEIVED
Tuesday, April 10, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 16, 2007PUBLISHED FOR OPPOSITION
Wednesday, December 27, 2006NOTICE OF PUBLICATION
Tuesday, November 28, 2006LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, November 27, 2006ASSIGNED TO LIE
Wednesday, November 15, 2006APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, September 16, 2006TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 27, 2006CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 27, 2006TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 9, 2006ASSIGNED TO EXAMINER
Thursday, January 5, 2006NON-FINAL ACTION MAILED
Thursday, January 5, 2006NON-FINAL ACTION WRITTEN
Thursday, January 5, 2006ASSIGNED TO EXAMINER
Monday, June 20, 2005NEW APPLICATION ENTERED IN TRAM